Ask a Question

Ask your question and our customer service team will answer it as soon as they can. Questions that do not contain personal information may be posted to our help center to be of service to others

* Required field

Your Email Address *

Please enter a valid email address.

Choose a Topic *

Tell us your question and any additional information *

Please enter all required fields.

Find a Clinical Trial

Are You Considering Taking Part in a Clinical Study?

Learn more about colorectal and liver cancer, answer a few brief questions to find out if you may qualify for a study, review a list of clinical studies that are now enrolling, and find other resources for support as you consider your next steps with colorectal or liver cancer.

You may qualify for a clinical trial.

Click Here to Learn More

divider

Jump to Studies

Colorectal Cancer (CRC) | Liver Cancer (HCC)

Gastrointestinal Cancer Clinical Trials

Thank You for Considering a Clinical Trial

We have several clinical trials that are currently recruiting to evaluate experimental medications for gastrointestinal (GI) cancers. See if there are clinical trials that might be right for you.
Below you will find clinical trials that are either currently recruiting patients (noted as Recruiting) or will be starting to recruit patients soon (noted as Not Yet Recruiting).

Here are some options for you to find more information:

Browse the trials available on your own and Click on View Trial Details for more information, including locations that are recruiting patients.
- or -
Let us help you find a trial: Pre-Screen Now and answer a few questions to determine if there is a trial that might be right for you.

divider

Colorectal Cancer Trials

CA209-9N9

Recruiting

An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread

View Trial Details

CA209-8HW

Recruiting

A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)

View Trial Details

CA224-123

Recruiting

A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer

View Trial Details

Liver Cancer Trials

CA224-106

Recruiting

A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer

View Trial Details

divider

Explore Gastrointestinal Cancer Resources

Hepatocellular Carcinoma by the Numbers

Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer.

Learn More

Learn More About Colorectal Cancer

Colorectal cancer, or CRC, is a cancer that forms in the tissues of the colon or rectum, which are part of the body’s digestive or gastrointestinal (GI) system.

Learn More

SELECTED SUPPORT ORGANIZATIONS AND DISEASE INFORMATION

Bristol Myers Squibb is not affiliated with nor endorses any of the listed organizations. The information/links provided by Bristol Myers Squibb are meant for informational purposes only and are not meant to replace a physician's medical advice or imply endorsement.

Gastric Cancer Overview National Cancer Institute Condition Overview

divider

We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information

Have questions? Live support is available 24/7 - Call 855-907-3286 or email clinical.trials@bms.com

Have questions? Live support is available 24/7 -

Call 855-907-3286 or email clinical.trials@bms.com